Cannabinoid CB 2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Open accessAbstract
Significance: Although early studies suggested that cannabinoid CB 2 receptors (CB 2 Rs) are absent in the brain, this view has been challenged by recent findings of significant brain CB 2 R involvement in several dopamine (DA)-related CNS disorders. The cellular mechanisms underlying these actions are unclear, however. Using multiple approaches, we found that CB 2 R genes and receptors are expressed in midbrain DA neurons, and that activation of CB 2 Rs inhibits DA neuronal firing and i.v. cocaine self-administration. These findings not only challenge the long-held view that brain CB 2 Rs are not expressed in neurons, but also suggest that neuronal CB 2 Rs modulate DA neuronal activity and DA-regulated behavior. Thus, brain CB 2 Rs may constitute a new therapeutic target in medication development for treatment of a number of CNS disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CB2 activation reduces ventral tegmental area dopamine neuron firing and immobility in forced-swim and tail-suspension tests.
“CB2 activation reduces VTA dopamine neuron firing [39] and immobility in forced-swim and tail-suspension tests [40].”
From The molecular and cellular mechanisms of depression: a focus on reward circuitry (2019) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works
(2012) · doi:10.1016/j.jmoldx.2011.08.002 · Cited by 2,567 · see citing works
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968 · see citing works
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works
Identification and Functional Characterization of Brainstem Cannabinoid CB<sub>2</sub>Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works
Tamamaki, N., Yanagawa, Y., Tomioka, R., Miyazaki, J., Obata, K., & Kaneko, T. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10905 · Cited by 1,277 · see citing works
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,065 · see citing works
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study
Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., & Watson, S. J. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903500307 · Cited by 872 · see citing works
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820 · see citing works
Self-citationCB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 633 · see citing works
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544 · see citing works
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 529 · see citing works
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., Yang, H.-J., Bi, G.-H., Li, J., & Gardner, E. L. (2011) · Nature Neuroscience · doi:10.1038/nn.2874 · Cited by 397 · see citing works
Self-citationSkaper, S. D., Buriani, A., Toso, R. D., Petrelli, L., Romanello, S., Facci, L., & Léon, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3984 · Cited by 374 · see citing works
Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS
Mansour, A., Fox, C. A., Burke, S., Akil, H., & Watson, S. J. (1995) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(95)00055-c · Cited by 370 · see citing works
Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 359 · see citing works
μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding
Mansour, A., Fox, C. A., Thompson, R. C., Akil, H., & Watson, S. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)90031-0 · Cited by 304 · see citing works
Marinelli, M., & White, F. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08876.2000 · Cited by 254 · see citing works
Liu, Q., Pan, C., Hishimoto, A., Li, C., Xi, Z., Llorente‐Berzal, A., Viveros, M., Ishiguro, H., Arinami, T., Onaivi, E. S., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00498.x · Cited by 248 · see citing works
Self-citationCannabinoid signaling in glial cells
Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 218 · see citing works
Viscomi, M. T., Oddi, S., Latini, L., Pasquariello, N., Florenzano, F., Bernardi, G., Molinari, M., & Maccarrone, M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0786-09.2009 · Cited by 212 · see citing works
García, C., Palomo‐Garo, C., Garcı́a-Arencibia, M., Ramos, J., Pertwee, R. G., & Fernández‐Ruíz, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01278.x · Cited by 211 · see citing works
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
Ashton, J. C., Friberg, D., Darlington, C. L., & Smith, P. F. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.038 · Cited by 208 · see citing works
Depression‐resistant endophenotype in mice overexpressing cannabinoid CB <sub>2</sub> receptors
García‐Gutiérrez, M., Pérez‐Ortiz, J., Gutiérrez‐Adán, A., & Manzanares, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00819.x · Cited by 196 · see citing works
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Ortega-Álvaro, A., Aracil-Fernández, A., García‐Gutiérrez, M. S., Navarrete, F., & Manzanares, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.34 · Cited by 187 · see citing works
den Boon, F. S., Chameau, P. J. P., Schaafsma-Zhao, Q., van Aken, W., Bari, M., Oddi, S., Kruse, C. G., Maccarrone, M., Wadman, W. J., & Werkman, T. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118167109 · Cited by 185 · see citing works
Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus
Brusco, A., Tagliaferro, P. A., Saez, T. M. M., & Onaivi, E. S. (2008) · Synapse · doi:10.1002/syn.20569 · Cited by 166 · see citing works
Elmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160 · see citing works
Sagar, D. R., Kelly, S., Millns, P. J., O'Shaughnessey, C. T., Kendall, D. A., & Chapman, V. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04206.x · Cited by 154 · see citing works
García-Gutiérrez, M. S., & Manzanares, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379507 · Cited by 153 · see citing works
Griffin, G., Wray, E. J., Tao, Q., McAllister, S. D., Rorrer, W. K., Aung, M. M., Martin, B. R., & Abood, M. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00402-1 · Cited by 148 · see citing works
Functional CB2 type cannabinoid receptors at CNS synapses
Morgan, N. H., Stanford, I. M., & Woodhall, G. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.017 · Cited by 137 · see citing works
García‐Gutiérrez, M. S., García‐Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01625.x · Cited by 136 · see citing works
Expression of CB2 cannabinoid receptor mRNA in adult rat retina
Lu, Q., Straiker, A. J., Lu, Q., & Maguire, G. (2000) · Visual Neuroscience · doi:10.1017/s0952523800171093 · Cited by 136 · see citing works
Lanciego, J. L., Barroso‐Chinea, P., Rico, A. J., Conte-Perales, L., Callén, L., Roda, E., Gómez-Bautista, V., López, I. P., Lluís, C., Labandeira-García, J. L., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367732 · Cited by 130 · see citing works
Functional Coupling between the Prefrontal Cortex and Dopamine Neurons in the Ventral Tegmental Area
Gao, M., Liu, C.-L., Yang, S., Jin, G.-Z., Bunney, B. S., & Shi, W.-X. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5347-06.2007 · Cited by 125 · see citing works
Self-citationAgudo, J., Martín, M., Roca, C., Molas, M., Bura, S. A., Zimmer, A., Bosch, F., & Maldonado, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1894-6 · Cited by 122 · see citing works
Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119 · see citing works
McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 115 · see citing works
The peripheral cannabinoid receptor knockout mice: an update
Buckley, N. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707527 · Cited by 112 · see citing works
Nackley, A. G., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00886.2003 · Cited by 111 · see citing works
Gao, M., Jin, Y., Yang, K., Zhang, D., Lukas, R. J., & Wu, J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1943-10.2010 · Cited by 99 · see citing works
Self-citationBrown, R. E., McKenna, J. T., Winston, S. H., Basheer, R., Yanagawa, Y., Thakkar, M. M., & McCarley, R. W. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06024.x · Cited by 92 · see citing works
Jhaveri, M. D., Elmes, S. J. R., Richardson, D., Barrett, D. A., Kendall, D. A., Mason, R., & Chapman, V. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06162.x · Cited by 88 · see citing works
Ignatowska-Jankowska, B. M., Muldoon, P. P., Lichtman, A. H., & Damaj, M. I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3117-6 · Cited by 83 · see citing works
Increased vulnerability to cocaine in mice lacking dopamine D 3 receptors
Song, R., Zhang, H., Li, X., Bi, G., Gardner, E. L., & Xi, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205297109 · Cited by 76 · see citing works
Self-citationYang, K., Hu, J., Lucero, L. M., Liu, Q., Zheng, C. J., Zhen, X., Jin, G.-Z., Lukas, R. J., & Wu, J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.162743 · Cited by 73 · see citing works
Self-citationCannabinoid CB2 receptor‐mediated regulation of impulsive‐like behaviour in DBA/2 mice
Navarrete, F., Pérez‐Ortiz, J. M., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01542.x · Cited by 72 · see citing works
Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Xi, Z., & Gardner, E. L. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030303 · Cited by 70 · see citing works
Self-citationWu, J., George, A. A., Schroeder, K. M., Xu, L., Marxer-Miller, S., Lucero, L. M., & Lukas, R. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070417 · Cited by 65 · see citing works
Self-citationCannabinoid CB2receptor expression in the rat brainstem cochlear and vestibular nuclei
Baek, J., Zheng, Y., Darlington, C. L., & Smith, P. F. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480701796944 · Cited by 55 · see citing works
Slow Oscillatory Firing: A Major Firing Pattern of Dopamine Neurons in the Ventral Tegmental Area
Shi, W. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00317.2005 · Cited by 42 · see citing works
Schmidt, W., Schäfer, F., Striggow, V., Fröhlich, K., & Striggow, F. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.080 · Cited by 38 · see citing works
Zhang, D., Gao, M., Xu, D., Shi, W., Gutkin, B. S., Steffensen, S. C., Lukas, R. J., & Wu, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5411-11.2012 · Cited by 29 · see citing works
Self-citationZhang, D., Yang, S., Jin, G.-Z., Bunney, B. S., & Shi, W. (2007) · Synapse · doi:10.1002/syn.20479 · Cited by 23 · see citing works
Behavioral Effects of Pulp Exposure in Mice Lacking Cannabinoid Receptor 2
Flake, N., & Zweifel, L. S. (2011) · Journal of Endodontics · doi:10.1016/j.joen.2011.09.015 · Cited by 20 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Garcia-Gutierrez MS, Garcia-Bueno B, Zoppi S, Leza JC, Manzanares J (2011) Chronic blockade of cannabinoid CB(2) receptors induces anxiolytic-like actions associated to alterations in GABA(A) receptors. Br J Pharmacol 165(4):951-64.
- Van Sickle MD, et al. (2005) Identification and functional characterization of brain- stem cannabinoid CB2 receptors. Science 310(5746):329-332.
- Morgan NH, Stanford IM, Woodhall GL (2009) Functional CB 2 type cannabinoid re- ceptors at CNS synapses. Neuropharmacology 57(4):356-368.
Cited by
Sorted by citations
The endocannabinoid system in guarding against fear, anxiety and stress
Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4036 · Cited by 506 · see citing works
The molecular and cellular mechanisms of depression: a focus on reward circuitry
Fox, M. E., & Lobo, M. K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0415-3 · Cited by 232 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1634086 · Cited by 144 · see citing works
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Grenald, S. A., Young, M. A., Wang, Y., Ossipov, M. H., Ibrahim, M. M., Largent-Milnes, T. M., & Vanderah, T. W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.008 · Cited by 97 · see citing works
Calina, D., Buga, A. M., Mitroi, M., Buha, A., Caruntu, C., Scheau, C., Bouyahya, A., El Omari, N., El Menyiy, N., & Docea, A. O. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082395 · Cited by 65 · see citing works
Shen, H., Marino, R. A. M., McDevitt, R. A., Bi, G.-H., Chen, K., Madeo, G., Lee, P.-T., Liang, Y., De Biase, L. M., Su, T.-P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800886115 · Cited by 58 · see citing works
Self-citationArgue, K. J., VanRyzin, J. W., Falvo, D. J., Whitaker, A. R., Yu, S. J., & McCarthy, M. M. (2017) · eneuro · doi:10.1523/eneuro.0344-16.2017 · Cited by 47 · see citing works
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Chesney, E., Oliver, D., & McGuire, P. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05905-9 · Cited by 40 · see citing works
- Authors
- Zhang, H.-Y., Gao, M., Liu, Q.-R., Bi, G.-H., Li, X., Yang, H.-J., Gardner, E. L., Wu, J., & Xi, Z.-X.
- Affiliations
- National Institute on Drug Abuse (US)
- Barrow Neurological Institute (US)
- University of California San Diego (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-11-03
- Volume
- 111
- Issue
- 46
- Pages
- E5007-15
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4246322
- OpenAlex
- W2135184362
- Cited by
- 334
- References
- 57
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 18 · 2023: 20 · 2022: 40 · 2021: 44 · 2020: 31 · 2019: 28 · 2018: 38 · 2017: 37 · 2016: 24 · 2015: 25
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Brigham Young University
- National Institutes of Health (GAD67)
- Indiana University Bloomington
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- CB2 receptor, ventral tegmental area, dopaminergic neurons, neuronal excitability, JWH-133, cocaine self-administration, CB2 knockout mice, CB1 receptor, midbrain dopamine
- MeSH terms
- Action Potentials, Animals, Appetitive Behavior, Cannabinoids, Cocaine, Dopamine, Feeding Behavior, Indoles, Male, Mice, Inbred C57BL, Microinjections, Nerve Tissue Proteins, Neuroglia, Reward, RNA, Messenger, Self Administration, Spleen, Ventral Tegmental Area, Mice, Knockout, Cocaine-Related Disorders, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Mice, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review